Catalyst Wire Dossier Catalyst Wire Dossier

Ofteno

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ofteno, covering 2019-10-28 to 2019-10-28. Get the full timeline:

Most recent: Clinical Trial Update: Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular Hypertension [Phase 3]

See pricing